Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine, Curcumin and Celebrex in Pancreatic Cancer
NCT00486460Phase 3Unknown
- Sponsor
- Tel Aviv Sourasky Medical Center
- Start
- Jun 2005
- Modality
- Nucleic Acid-Directed Small Molecules, Orthosteric Ligands, Covalent Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of celecoxib, curcumin in pancreatic cancer (PC), sponsored by Tel Aviv Sourasky Medical Center. Status: unknown.
02
Drugs
celecoxibcurcumin
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00486460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00486460.